Featured Events
2026
September 29: Dr. Jashvant Unadkat is invited to give a talk on “Pursuing the holy grail of predicting human fetal exposure to drugs throughout pregnancy” at the “Maternal-Fetal and Neonatal Pharmacology: Integrating Clinical Insight and Modeling to Advance Drug Therapy in Fetal and Neonatal Care” symposium at the 2026 American College of Clinical Pharmacology (ACCP) Annual Meeting (N Bethesda, MD).
August: Dr. Jashvant Unadkat is invited to present his work on predicting maternal-fetal disposition of drugs at three Universities in Africa: Kamuzu University of Health Sciences (KUHeS) (Blantyre, Malawi), United States International University-Africa (Nairobi, Kenya), and Makerere University College of Health Sciences (Kampala, Uganda).
July 12-17: Dr. Jashvant Unadkat is invited to give a plenary talk on “New Approach Methodologies (NAMs) to Predict Transporter-Based ADME Including Tissue Drug Exposure” at the 2026 Drug Metabolism Gordon Research Conference (Holderness, New Hampshire).
May 30 – June 3: Dr. Edward Kelly, co-chairing the session on novel cell, organoid, and micro-physiological systems for the study of microsomal drug metabolism and toxicity, gives a talk on “New Approach Methodologies for Modeling Drug/Xenobiotic Metabolism and Toxicity” in The 26th International Symposium on Microsomes and Drug Oxidations (Hong Kong, China).
May 27: Dr. Jashvant Unadkat is invited to give a plenary talk on “New Approach Methodologies to Predict Transporter-Based Human Tissue Drug Concentrations” at the New England Drug Metabolism Group Discussion Symposium in Boston, MA.
April 17: Dr. Jashvant Unadkat presents on behalf of UWTEC at a NICHD (Eunice Kennedy Shriver National Institute of Child Health and Human Development) Science Friday seminar to the NICHD leadership about research conducted by UWTEC, one of four grants funded nationwide by NICHD.
April 13-17: Dr. Edward Kelly gives a talk “Modeling Transporter Ontogeny in Human Intestinal Organoids” in the MPRINT Annual Meeting (Indianapolis, IN) in the session “TENS: Human-Relevant Organoids and Tissue Chips as New Approach Methodologies for Advancing Perinatal Pharmacotherapeutics”.
April 3: The School of Pharmacy and the division of Maternal-Fetal Medicine launch a quarterly seminar series titled “Maternal-fetal pharmacology and medicine”. Drs. Samuel Arnold (“Gestational Age Associated Changes in Xenobiotic and Nutrient Transporters in the Human Placenta“) and Stephen McCartney (“Dynamic Decidual Immunometabolism in Pregnancy“) give talks at the first seminar on Apr. 3rd. [Read more]
March 22-25: Dr. Edward Kelly chairs a session on New Approach Methods at the Society of Toxicology Annual Meeting in San Diego.
February 26: Dr. Edward Kelly gives a talk at the UW School of Public Health weekly seminar series titled “So What Are New Approach Methodologies and How Can We Apply Them in Safety/Risk Assessment?”
February 25: Dr. Edward Kelly is recently interviewed by journalist Diana Kwon, where he shares his thoughts on the utility and limitations of “new approach methodologies”. (News Feature on Nature: The age of animal experiments is waning. Where will science go next?)
February 22: New publication alert! Potential integration of multiple organs-on-a-chip for comprehensive drug-drug interaction prediction.
2025
November 21: New publication alert! Effect of proinflammatory cytokines on intestinal drug transporters in human enteroid monolayers.
November 6-8: Dr. Edward Kelly attends the SEDS-USA, Space-Visions 2025 Annual Conference held at Seattle, WA as a panelist for workshop “Doctor, We Have a Problem: Space Medicine“.
August 4: The Kelly Lab takes part in a STEM camp sponsored by UW ISCRM down at W.F.-West High School in Chehalis, WA to discuss “New Approach Methodologies for Medical Research” with students there. [Read more]
July 21: New publication alert! Leveraging RNA-seq deconvolution to improve complex in vitro model characterization.
June 1-3: Dr. Edward Kelly gives a talk “Micro-Physiological Systems: What are the Potential Contexts of use in Drug-Drug and Drug-Natural Product Interactions?” in the 15th Annual Drug-Drug Interaction Workshop at Marbach Castle, Germany.
May 19: New publication alert! Human intestinal enteroids: Nonclinical applications for predicting oral drug disposition, toxicity, and efficacy.
May 3: New publication alert! A gut response: Application of human enteroid monolayers to probe the mechanism of the goldenseal-mediated inhibition of metformin intestinal absorption.
2024
March: A documentary film crew interviews Dr. Edward Kelly’s lab members about their work on “alternatives to animal research”. (The documentary: Sentient | 2026 Sundance Film Festival; An interview with the director – Tony Jones: Tony Jones On Whether Animals Are ‘Sentient’ In New Documentary At Sundance – YouTube)